Funding to be used for host of trials: Cancer genomics firm Inivata pulls in $42M in series A funding Jan. 27, 2016 By Nuala Moran LONDON – Inivata Ltd. has raised £31.5 million (US$42.2 million) in a series A round, to advance the commercialization of its circulating tumor DNA liquid biopsy technology.Read More
Inside the Beltway: NICE offers favorable review of AMS's Greenlight for BPH Jan. 27, 2016 By Mark McCarty
Firm finds niche in cardiovascular monitoring: Irhythm finds its groove in both wearable, digital health markets Jan. 27, 2016 By Omar Ford
Hold placed on Califf nomination: Senate hostage-taking snares confirmation of FDA head Jan. 27, 2016 By Mari Serebrov
RSS